Breast Cancer
Phase II, multicenter, open-label, clinical trial of Trabectedin (Yondelis?) in Metastatic Breast Cancer Patients with triple negative profile (ER-, PR-, HER2-), HER2 overexpressing tumors and BRCA1 or BRCA2 mutation carriers.
Trial ID: 06166
Contact: Parinaz Pezeshki
Phone: (281)863-4643
Learn More about this trial.
go back | new search